• 1
    Kaufmann S. Towards new leprosy and tuberculosis vaccines. Microbiol Sci 1987; 4:3248.
  • 2
    Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125:815.
  • 3
    Young LS, Inderlied B, Berlin OG, Gottlieb MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986; 8:102433.
  • 4
    Canetti G. The tubercle bacillus in the pulmonary lesion in man. New York: Springer Publishing Co., 1955.
  • 5
    Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Microbiol 2003; 1:97105.
  • 6
    Smith D, Harding G, Chan J et al. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J Biol Stand 1979; 7:17997.
  • 7
    Udani PM. BCG vaccination in India and tuberculosis in children: newer facets. Indian J Pediatr 1994; 61:45162.
  • 8
    Roche PW, Triccas JA, Winter N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 1995; 3:397401.
  • 9
    Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990; 145:14954.
  • 10
    Debout C, Quillec M, Izard J. New data on the cytolytic effects of natural killer cells (Kurloff cells) on a leukemic cell line (guinea pig L2C). Leuk Res 1999; 23:13747.
  • 11
    Mackaness GB. The immunology of antituberculous immunity. Am Rev Respir Dis 1969; 97:33744.
  • 12
    Orme IM, Miller ES, Roberts AD et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992; 148:18996.
  • 13
    Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:22437.
  • 14
    Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56:73140.
  • 15
    Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:224954.
  • 16
    Holscher C, Atkinson RA, Arendse B et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001; 167:695766.
  • 17
    Verreck FA, De Boer T, Langenberg DM et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101:45605.
  • 18
    Flesch IE, Kaufmann SH. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun 1990; 58:26757.
  • 19
    Kemijo R, Le J, Shapiro D et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with bacillus Calmette–Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:143540.
  • 20
    Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101:23649.
  • 21
    Holt PG. Regulation of antigen presenting cell(s) in lung and airway tissues. Eur Respir J 1993; 6:1209.
  • 22
    McCombs CC, Michalski JP, Westerfield BT, Light RW. Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes. Chest 1982; 82:26671.
  • 23
    Upham JW, Strickland DH, Bilyk N, Robinson BW, Holt PG. Alveolar macrophages from humans and rodents selectively inhibit T cell proliferation but permit T cell activation and cytokine secretion. Immunology 1995; 84:1427.
  • 24
    Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993; 177:17737.
  • 25
    Holt PG. Alveolar macrophages. I. Inhibition of lymphocyte proliferation by purified macrophages from rat lung. Immunology 1979; 37:42936.
  • 26
    Holt PG. Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures. Cell Immunol 1980; 50:2105.
  • 27
    Zhang X, McMurray DN. Suppression of lymphoproliferation by alveolar macrophages in the guinea pig. Tuber Lung Dis 1998; 79:11926.
  • 28
    Allen SS, McMurray DN. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect Immun 2003; 71:42717.
  • 29
    Cho H, Lasco TM, Sedberry S, Yoshimura T, McMurray DN. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun 2005; 73:136776.
  • 30
    Jeevan A, Yoshimura T, Foster G, McMurray DN. Effect of BCG infection on interleukin-1β and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect Immun 2002; 70:124553.
  • 31
    Jeevan A, Yoshimura T, Lee KE, McMurray DN. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect Immun 2003; 71:35464.
  • 32
    Lasco TM, Yamamoto T, Yoshimura T, Allen SS, Cassone L, McMurray DN. Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect Immun 2003; 71:703542.
  • 33
    Lyons MJ, Yoshimura T, McMurray DN. Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun 2002; 70:54718.
  • 34
    Jeevan A, McFarland CT, Yoshimura T et al. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun 2006; 74:21324.
  • 35
    Lasco TM, Cassone L, Kamohara H, Yoshimura T, McMurray DN. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis 2005; 85:24558.
  • 36
    Lyons MJ, Yoshimura T, McMurray DN. Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis. Tuberculosis 2004; 84:28392.
  • 37
    Skwor TA, Cho H, Cassidy C, Yoshimura T, McMurray DN. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages. J Leukoc Biol 2004; 7:122939.
  • 38
    Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 2001; 69:266674.
  • 39
    Lyadova IV, Eruslanov EB, Khaidukov SV et al. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol 2000; 165 (10):592131.
  • 40
    Cho H, McMurray DN. Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages. Infect Immun 2005; 73:843741.
  • 41
    Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55:28390.
  • 42
    Cohen MK, Bartow RA, Mintzer CL, McMurray DN. Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs. Infect Immun 1987; 55:3149.
  • 43
    Yamamoto T, Jeevan A, Ohishi K et al. A new assay system for guinea pig interferon biological activity. J Interferon Cytokine Res 2002; 22:7937.
  • 44
    Antony VB, Sahn SA, Harada RN, Repine JE. Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes. Chest 1983; 83:S956.
  • 45
    Appleberg R, Silva MT. T cell dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol 1989; 78:47848.
  • 46
    Lasco TM, Turner OC, Cassone L et al. Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 2004; 72:11479.
  • 47
    Pouliot N, Maghni K, Sirois P, Rola-Pleszczynski M. Guinea pig Kurloff (NK-like) cells mediate TNF-dependent cytotoxic activity: analogy with NC effector cells. Inflammation 1996; 20:26380.
  • 48
    Holt PG. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin Exp Immunol 1986; 63:26170.
  • 49
    Upham JW, Strickland DH, Robinson BW, Holt PG. Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages. Thorax 1997; 52:78695.
  • 50
    Bilyk N, Holt PG. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 1995; 86:31237.
  • 51
    Raqib R, Ljungdahl A, Lindberg AA, Wretlind B, Andersson U, Andersson J. Dissociation between cytokine mRNA expression and protein production in shigellosis. Eur J Immunol 1996; 26:11308.
  • 52
    Fultz MJ, Barber SA, Dieffenbach CW, Vogel SN, Bloom BR. Induction of IFN-γ in macrophages by lipopolysaccharide. Int Immunol 1993; 5:138392.
  • 53
    Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999; 103:10239.
  • 54
    Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997; 65:514956.